Literature DB >> 19765293

NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction.

Morten Nielsen1, Ole Lund.   

Abstract

BACKGROUND: The major histocompatibility complex (MHC) molecule plays a central role in controlling the adaptive immune response to infections. MHC class I molecules present peptides derived from intracellular proteins to cytotoxic T cells, whereas MHC class II molecules stimulate cellular and humoral immunity through presentation of extracellularly derived peptides to helper T cells. Identification of which peptides will bind a given MHC molecule is thus of great importance for the understanding of host-pathogen interactions, and large efforts have been placed in developing algorithms capable of predicting this binding event.
RESULTS: Here, we present a novel artificial neural network-based method, NN-align that allows for simultaneous identification of the MHC class II binding core and binding affinity. NN-align is trained using a novel training algorithm that allows for correction of bias in the training data due to redundant binding core representation. Incorporation of information about the residues flanking the peptide-binding core is shown to significantly improve the prediction accuracy. The method is evaluated on a large-scale benchmark consisting of six independent data sets covering 14 human MHC class II alleles, and is demonstrated to outperform other state-of-the-art MHC class II prediction methods.
CONCLUSION: The NN-align method is competitive with the state-of-the-art MHC class II peptide binding prediction algorithms. The method is publicly available at http://www.cbs.dtu.dk/services/NetMHCII-2.0.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765293      PMCID: PMC2753847          DOI: 10.1186/1471-2105-10-296

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  32 in total

1.  Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.

Authors:  A J Godkin; K J Smith; A Willis; M V Tejada-Simon; J Zhang; T Elliott; A V Hill
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Towards the in silico identification of class II restricted T-cell epitopes: a partial least squares iterative self-consistent algorithm for affinity prediction.

Authors:  I A Doytchinova; D R Flower
Journal:  Bioinformatics       Date:  2003-11-22       Impact factor: 6.937

3.  Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules.

Authors:  Hideki Noguchi; Ryuji Kato; Taizo Hanai; Yukari Matsubara; Hiroyuki Honda; Vladimir Brusic; Takeshi Kobayashi
Journal:  J Biosci Bioeng       Date:  2002       Impact factor: 2.894

Review 4.  Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture.

Authors:  F Castellino; G Zhong; R N Germain
Journal:  Hum Immunol       Date:  1997-05       Impact factor: 2.850

5.  Capacity of intact proteins to bind to MHC class II molecules.

Authors:  A Sette; L Adorini; S M Colon; S Buus; H M Grey
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

Review 6.  Measuring the accuracy of diagnostic systems.

Authors:  J A Swets
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

7.  Prediction of MHC class II binding peptides based on an iterative learning model.

Authors:  Naveen Murugan; Yang Dai
Journal:  Immunome Res       Date:  2005-12-13

8.  A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach.

Authors:  Peng Wang; John Sidney; Courtney Dow; Bianca Mothé; Alessandro Sette; Bjoern Peters
Journal:  PLoS Comput Biol       Date:  2008-04-04       Impact factor: 4.475

9.  Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund
Journal:  BMC Bioinformatics       Date:  2007-07-04       Impact factor: 3.169

10.  Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms.

Authors:  Menaka Rajapakse; Bertil Schmidt; Lin Feng; Vladimir Brusic
Journal:  BMC Bioinformatics       Date:  2007-11-22       Impact factor: 3.169

View more
  208 in total

1.  Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign.

Authors:  Massimo Andreatta; Morten Nielsen
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

2.  Predicting MHC-II binding affinity using multiple instance regression.

Authors:  Yasser EL-Manzalawy; Drena Dobbs; Vasant Honavar
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2011 Jul-Aug       Impact factor: 3.710

Review 3.  MHC class II epitope predictive algorithms.

Authors:  Morten Nielsen; Ole Lund; Søren Buus; Claus Lundegaard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

4.  The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.

Authors:  Christina Bade-Döding; Alex Theodossis; Stephanie Gras; Lars Kjer-Nielsen; Britta Eiz-Vesper; Axel Seltsam; Trevor Huyton; Jamie Rossjohn; James McCluskey; Rainer Blasczyk
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

5.  Epitope specific T-cell responses against influenza A in a healthy population.

Authors:  Miloje Savic; Jennifer L Dembinski; Yohan Kim; Gro Tunheim; Rebecca J Cox; Fredrik Oftung; Bjoern Peters; Siri Mjaaland
Journal:  Immunology       Date:  2015-12-08       Impact factor: 7.397

6.  Identification of Marker Genes for Cancer Based on Microarrays Using a Computational Biology Approach.

Authors:  Xiaosheng Wang
Journal:  Curr Bioinform       Date:  2014-04-01       Impact factor: 3.543

7.  Improved methods for predicting peptide binding affinity to MHC class II molecules.

Authors:  Kamilla Kjaergaard Jensen; Massimo Andreatta; Paolo Marcatili; Søren Buus; Jason A Greenbaum; Zhen Yan; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

8.  Developing strategies to enhance and focus humoral immune responses using filamentous phage as a model antigen.

Authors:  Kevin A Henry; Armstrong Murira; Nienke E van Houten; Jamie K Scott
Journal:  Bioeng Bugs       Date:  2011-09-01

9.  Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.

Authors:  Laura A Muruato; Daniel Tapia; Christopher L Hatcher; Mridul Kalita; Paul J Brett; Anthony E Gregory; James E Samuel; Richard W Titball; Alfredo G Torres
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

Review 10.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.